- Home
- GOVX vs BIYA Comparison
GOVX vs BIYA Comparison
Compare GOVX & BIYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- BIYA
- Stock Information
- Founded
- GOVX 2001
- BIYA 2017
- Country
- GOVX United States
- BIYA China
- Employees
- GOVX N/A
- BIYA N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- BIYA
- Sector
- GOVX Health Care
- BIYA
- Exchange
- GOVX Nasdaq
- BIYA NYSE
- Market Cap
- GOVX 7.6M
- BIYA 7.8M
- IPO Year
- GOVX N/A
- BIYA 2025
- Fundamental
- Price
- GOVX $0.75
- BIYA $0.92
- Analyst Decision
- GOVX Strong Buy
- BIYA
- Analyst Count
- GOVX 4
- BIYA 0
- Target Price
- GOVX $10.50
- BIYA N/A
- AVG Volume (30 Days)
- GOVX 2.7M
- BIYA 2.7M
- Earning Date
- GOVX 08-05-2025
- BIYA 05-13-2025
- Dividend Yield
- GOVX N/A
- BIYA N/A
- EPS Growth
- GOVX N/A
- BIYA N/A
- EPS
- GOVX N/A
- BIYA N/A
- Revenue
- GOVX $5,591,576.00
- BIYA $12,809,211.00
- Revenue This Year
- GOVX N/A
- BIYA N/A
- Revenue Next Year
- GOVX N/A
- BIYA N/A
- P/E Ratio
- GOVX N/A
- BIYA N/A
- Revenue Growth
- GOVX N/A
- BIYA 10.66
- 52 Week Low
- GOVX $0.43
- BIYA $0.59
- 52 Week High
- GOVX $11.18
- BIYA $8.00
- Technical
- Relative Strength Index (RSI)
- GOVX 47.67
- BIYA N/A
- Support Level
- GOVX $0.60
- BIYA N/A
- Resistance Level
- GOVX $0.76
- BIYA N/A
- Average True Range (ATR)
- GOVX 0.08
- BIYA 0.00
- MACD
- GOVX 0.02
- BIYA 0.00
- Stochastic Oscillator
- GOVX 59.45
- BIYA 0.00
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About BIYA BAIYA INTERNATIONAL GROUP INC
Baiya International Group Inc is a company which operates through its subsidiary Gongwuyuan operates a cloud-based internet platform to provide one-stop crowdsourcing recruitment and SaaS-enabled HR solutions in the flexible employment marketplace. The Company's business is focused around on four primary services which are job matching services, entrusted recruitment services, project outsourcing services and abor dispatching services in the flexible employment market within China, mainly in the core manufacturing regions including the Pearl River Delta and Yangtze River Delta region.